(19)
(11) EP 3 712 147 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.04.2023 Bulletin 2023/17

(45) Mention of the grant of the patent:
25.01.2023 Bulletin 2023/04

(21) Application number: 19735712.2

(22) Date of filing: 04.01.2019
(51) International Patent Classification (IPC): 
C07H 15/14(2006.01)
A61K 31/381(2006.01)
A61K 31/351(2006.01)
A61P 3/10(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 3/10; C07H 15/14
(86) International application number:
PCT/CN2019/070336
(87) International publication number:
WO 2019/134667 (11.07.2019 Gazette 2019/28)

(54)

SGLTS INHIBITOR AND APPLICATION THEREOF

SGLTS-INHIBITOR UND ANWENDUNG DAVON

INHIBITEUR DE SGLTS ET SON UTILISATION


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 05.01.2018 CN 201810012284

(43) Date of publication of application:
23.09.2020 Bulletin 2020/39

(73) Proprietor: Shandong Danhong Pharmaceutical Co., Ltd.
Heze, Shandong 274000 (CN)

(72) Inventors:
  • WU, Chengde
    Shanghai 200131 (CN)
  • MAO, Qinghua
    Shanghai 200131 (CN)
  • LI, Yi
    Shanghai 200131 (CN)
  • YU, Tao
    Shanghai 200131 (CN)
  • CHEN, Shuhui
    Shanghai 200131 (CN)

(74) Representative: Groth & Co. KB 
P.O. Box 6107
102 32 Stockholm
102 32 Stockholm (SE)


(56) References cited: : 
EP-A1- 2 634 184
WO-A1-2015/032272
CN-A- 101 503 399
CN-A- 102 453 026
CN-A- 104 109 154
EP-A1- 2 661 256
WO-A2-2008/042688
CN-A- 102 146 066
CN-A- 103 458 875
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).